Skip to main content
. 2020 Oct 29;3(1):vdaa149. doi: 10.1093/noajnl/vdaa149

Figure 2.

Figure 2.

Targeting glutamine metabolism reduces glioma cell growth. (A) Cell viability was performed in cancer cells treated with JAM326 or JHU-083 (72 h). Cell viability is visualized by a color scale. (B) Neurosphere forming assay was performed in cells cultured in serum-free media and treated with JHU-083. (C) Colony-forming assay was performed in adherent glioblastoma cells treated with JAM326 or JHU-083. Colony numbers are visualized by a color scale. (D) Cell viability was performed in IDH1R132H isogenic cells treated with JHU-083 (96 h). IDH1R132H protein expression was analyzed by Western blot. *P < .05; **P < .01; ***P < .001; ****P < .0001 versus Control. Doxy: doxycycline.